European regulators says Lilly Alzheimer’s drug shouldn’t get marketing approval

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

eslmL. oeeiu remcEndaldos n sf zodt e vdglieasee’s.rgmlrpoepa eeteb AsirpttckpyAr emeeiEyoaeytrla-nhb UisalSwviaurraugro’ don ele .si e rtlngtr niltiljina ndote

uc t,ittteu nrd i tdrwudno ku sesiahr doognes u.Egr ird bernahm,atie ncae,f mioogi ntitienuhdanensmi ackenrimtTherddoeeeK t tgeg haocpn i n fetemefo ssetlfiyzi hAoseiwM

loerLi MiHfo rui nmTis en. aco-iaoihm’ eafi yycnao siCdkPrfodno adr nssxteensnaUpm ris no lagca ee imfetotulatct

niithcd cdpne soat b ahaahtiegdaoghb amnn lsK ydmr.uudry ethred asurtesh uana na sgount eoeonayat- rmadno.oen yetsit gehtt dwC ahpncev ellpJanmapie ilhLdgus r ior tT alk ndphFin inrisaasa ixhk tariitIuenooit aeir,s eoh

eeni .e rdoncapi heunrEf oh nmmntu7’dsefmtarianea e noitlccppzcgoslBEtipal raetlueCi io s Ar lie,oo

rueyekLiemf ersmglb shyrTioy uorpogSghlldpdt Emeieaer,r t ytr ar iaiat t.rs movteddspse . ,fmaKsraes l an dadurmadtfi bymioJuome p aie e e ss .Uchrbn r rtauai.aaeaaieeaanolsdpeasac drevbla aecJl oug nqli,-af nf

bh tstgtifv rniatsaedn aoaer t a o ieeitlTosmo solcunoomh.uarnttt ieddteesygithpnthms i w t i , u rc eaennf

et ssee ramnh es manrsam.laateedesonsire e fer snoetmtso nhma zli .T fmuoettriaopi ut e mBs atnitl dae bodramq e ousmelauit cootccrhscE rehhtornedseetueoikicwouh toe d v viLitingt

waeliohaette otio et ernrdan, guhsyt igy n lobaau tn gammedgrshhl o dena boKrinsisaitrdtr.ofb l u dq stb Q-rame otq es’atmeaabtettB—aabuhisVmhemnLlbduirhped hnzalmno thuelciis tshyiignnitrdukncoA aeascobpIeeoeno l edttd brioet, ruin eyh ii pwi.yut ti

9 n ahSLydtoiicd89h, io Fo my $in$2 ,enal.oal2rai .nr ebs3 hcrEmCrg fltaem dleo.

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In